GlassScriptPhysician profile
Joseph Worischeck
NPI 1902870173
$2,440.84
in general payments reported to CMS, 2019-2025
31 companies · $466 in 2025
The $466 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $183 · 2021: $421 · 2022: $314 · 2023: $439 · 2024: $401 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,293 · Education: $13.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,293.11 |
| Education | $13.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $506.22 | 2021-2025 | Lupron Depot, Botox |
| Astellas Pharma US INC | $191.41 | 2020-2023 | Xtandi |
| Boston Scientific Corporation | $177.99 | 2019-2025 | Spaceoar Vue System - 10ml, Axonics |
| Sumitomo Pharma America, INC. | $177.38 | 2023-2025 | Orgovyx, Gemtesa |
| Coloplast Corp | $158.35 | 2019-2024 | Speedicath, Luja Coude |
| Myriad Genetic Laboratories, INC. | $137.87 | 2020-2023 | Prolaris |
| Pfizer INC. | $126.77 | 2019-2024 | |
| Rochester Medical Corporation | $111.26 | 2021-2022 | |
| Axonics, INC. | $85.93 | 2021-2023 | Axonics |
| Janssen Biotech, INC. | $76.55 | 2019-2023 | Erleada |
| Procept Biorobotics Corporation | $69.96 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $68.38 | 2020-2023 | Lynparza |
| Myovant Sciences INC. | $56.43 | 2021 | |
| Medtronic, INC. | $46.72 | 2022 | |
| Olympus America INC. | $42.02 | 2025 | Itind System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $36.62 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $34.45 | 2020-2023 | Bard Urinary Drainage Bag |
| Ferring Pharmaceuticals INC. | $33.90 | 2024-2025 | Adstiladrin |
| Ambu INC. | $32.42 | 2024 | |
| Endo Pharmaceuticals INC. | $32.14 | 2020-2021 | |
| Angiodynamics, INC. | $27.80 | 2023 | Nanoknife |
| Baxter Healthcare | $27.58 | 2025 | Tisseel |
| 180 Medical, INC. | $26.82 | 2024 | Gentlecath |
| Bioprotect Medical, INC. | $26.19 | 2025 | Bioprotect Balloon Implant System |
| Janssen Pharmaceuticals, INC | $25.62 | 2019 | |
| Progenics Pharmaceuticals, INC. | $25.41 | 2024 | |
| Alnylam Pharmaceuticals INC. | $20.70 | 2021 | |
| Amgen INC. | $17.20 | 2021 | |
| Isoray, INC | $14.53 | 2020 | |
| Photocure INC | $14.26 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Worischeck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.